Abstract:
Verimetra Inc. and a Pittsburgh-based team of medical and robotic researchers have begun testing what could lead to groundbreaking fetal surgeries. Verimetra has embedded a microsensor and a series of bar codes on the tip of a catheter used in balloon angioplasties before inserting it into a rat, whose heart is similar in size to that of a 20- to 24-week-old fetus.